APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial

被引：0
|
作者：
Li, Wenxiao [1 ,2 ,3 ,4 ]
Hu, Yongxian [1 ,2 ,4 ,5 ]
Zhang, Mingming [1 ,2 ,4 ,5 ]
Lai, Xinyi [1 ,2 ,4 ,5 ]
Zhao, Mengyu [1 ,2 ,4 ,5 ]
Fu, Shan [1 ,2 ,4 ,5 ]
Hong, Ruimin [1 ,2 ,4 ,5 ]
Chang, Alex H. [6 ]
Huang, He [1 ,2 ,4 ,7 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Liangzhu Lab, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[5] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
[6] Shanghai Yake Biotechnol Co Ltd, Shanghai, Peoples R China
[7] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-209660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7229 / 7229
页数：1
相关论文
共 50 条
  • [41] Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
    Jin, Chunxiang
    Chen, Rongrong
    Fu, Shan
    Zhang, Mingming
    Teng, Yuanyin
    Yang, Tingting
    Song, Fengmei
    Feng, Jingjing
    Hong, Ruimin
    Cui, Jiazhen
    Huang, Simao
    Xu, Huijun
    Zhang, Yanlei
    Wei, Guoqing
    Cai, Zhen
    Kwong, Yok-Lam
    Chan, Thomas Sau Yan
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [42] Real World Outcomes with Idecabtagene Vicleucel ( Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Sidana, Surbhi
    Ahmed, Nausheen
    Akhtar, Othman S.
    Heim, Michael
    Brazauskas, Ruta
    Hansen, Doris K.
    Ferreri, Christopher
    Freeman, Ciara Louise L.
    Afrough, Aimaz
    Anderson, Larry D., Jr.
    Dhakal, Binod
    Dhanda, Devender
    Gowda, Lohith
    Hashmi, Hamza
    Harrison, Melanie
    Kitali, Amani
    Mirza, Sayeef
    Patel, Jinalben
    Patwardhan, Pallavi
    Usmani, Saad Z.
    Patel, Krina K.
    Ganguly, Siddhartha
    Pasquini, Marcelo
    BLOOD, 2023, 142
  • [43] CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity
    Krejci, Martin
    Adam, Zdenek
    Krejci, Marta
    Pour, Ludek
    Sandecka, Viera
    Stork, Martin
    NEOPLASMA, 2022, 69 (05) : 1008 - 1018
  • [44] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [45] A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma
    Zhang, Hua
    Gao, Lei
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Kong, Peiyan
    Liu, Jia
    He, Jiaping
    Han, Yu
    Shi, Hua
    He, Yan
    Ye, Xun
    Zhao, Yi
    Cao, Wei
    Shen, Lianjun
    Zhang, Xi
    BLOOD, 2019, 134
  • [46] Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia
    Bu, Chaoke
    Peng, Zhiyong
    Luo, Min
    Li, Guangchao
    Li, Chunfu
    BLOOD, 2020, 136
  • [47] A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma
    Jung, Sung-Hoon
    Lee, Hyun-Ju
    Lee, Youn-Kyung
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Lee, Joon Haeng
    Emmich, Frank
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E129 - E130
  • [48] A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma
    Jung, Sung-Hoon
    Lee, Hyun-Ju
    Lee, Youn-Kyung
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Rhee, Joon Haeng
    Emmrich, Frank
    Lee, Je-Jung
    ONCOTARGET, 2017, 8 (25) : 41538 - 41548
  • [49] Advances in CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials in the Last Two Years
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Zubair, Hina
    Butt, Sigmone Khalid
    Anwar, Muhammad Yasir
    Hamza, Mohammad
    Nanjundaiah, Nikhilesh
    Chemarthi, Venkata Sireesha
    Shaaban, Hamid
    Guron, Gunwant
    Maroules, Michael
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S485 - S486
  • [50] SWASTH: Phase 1/2 Study of Ribrecabtagene Autoleucel, a BCMA-Directed CAR-T Cell Therapy, in Relapsed-Refractory Multiple Myeloma
    Menon, Hari
    Bharagava, Rahul
    Lokireddy, Padmaja
    Narayanan, Prasad
    Nataraj, K. S.
    Kumar, Akhil
    Mandavia, Divyesh
    Ramachandra, Murali
    Mathews, Vikram
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S65 - S65
12345